Skip to content

Slot: treats

Holds between a substance, procedure, or activity and a medical condition (disease or phenotypic feature), and states that the substance, procedure, or activity is able to ameliorate, stabilize, or cure the condition or delay, prevent, or reduce the risk of it manifesting in the first place. ‘Treats’ edges should be asserted (knoweldge_level: assertion) only in cases where there is strong supporting evidence - i.e. the intervention is approved or in phase 4 trials for the condition, or is a well-established treatment in the medical community. In the absence of such evidence, weaker predicates should be used in asserted edges (e.g. ‘in clinical trials for’ or ‘beneficial in models of’). ‘Treats’ edges based on weaker or indirect forms of evidence can however be created as predictions (knowledge_level: prediction) and should point to the more foundational asserted edges that support them.

URI: biolink:treats

Mixin Usage

mixed into description range domain
ameliorates_condition Holds between an entity and an existing medical condition (disease or phenoty... disease or phenotypic feature
preventative_for_condition Holds between a substance, procedure, or activity and a medical condition (di... disease or phenotypic feature

Properties

Aliases

  • is substance that treats
  • indicated for
  • ameliorates or prevents condition

Identifier and Mapping Information

Annotations

property value
canonical_predicate True

Schema Source

  • from schema: https://w3id.org/biolink/biolink-model

LinkML Source

name: treats
annotations:
  canonical_predicate:
    tag: canonical_predicate
    value: true
description: 'Holds between a substance, procedure, or activity and a medical condition
  (disease or phenotypic feature),  and states that the substance, procedure, or activity
  is able to ameliorate, stabilize, or cure the condition  or delay, prevent, or reduce
  the risk of it manifesting in the first place. ‘Treats’ edges should be asserted  (knoweldge_level:
  assertion) only in cases where there is strong supporting  evidence - i.e. the intervention
  is approved or in phase 4 trials for the condition, or is a well-established  treatment
  in the medical community. In the absence of such evidence, weaker predicates should
  be used in  asserted edges (e.g. ‘in clinical trials for’ or ‘beneficial in models
  of’). ‘Treats’ edges based on weaker  or indirect forms of evidence can however
  be created as predictions (knowledge_level: prediction) and should  point to the
  more foundational asserted edges that support them.'
in_subset:
- translator_minimal
from_schema: https://w3id.org/biolink/biolink-model
aliases:
- is substance that treats
- indicated for
- ameliorates or prevents condition
exact_mappings:
- DRUGBANK:treats
- SEMMEDDB:TREATS
- WIKIDATA_PROPERTY:P2175
related_mappings:
- MONDO:disease_responds_to
narrow_mappings:
- RO:0002606
- NCIT:regimen_has_accepted_use_for_disease
- REPODB:clinically_tested_approved_unknown_phase
- REPODB:clinically_tested_suspended_phase_0
- REPODB:clinically_tested_suspended_phase_1
- REPODB:clinically_tested_suspended_phase_1_or_phase_2
- REPODB:clinically_tested_suspended_phase_2
- REPODB:clinically_tested_suspended_phase_2_or_phase_3
- REPODB:clinically_tested_suspended_phase_3
- REPODB:clinically_tested_terminated_phase_0
- REPODB:clinically_tested_terminated_phase_1
- REPODB:clinically_tested_terminated_phase_1_or_phase_2
- REPODB:clinically_tested_terminated_phase_2
- REPODB:clinically_tested_terminated_phase_2_or_phase_3
- REPODB:clinically_tested_terminated_phase_3
- REPODB:clinically_tested_withdrawn_phase_0
- REPODB:clinically_tested_withdrawn_phase_1
- REPODB:clinically_tested_withdrawn_phase_1_or_phase_2
- REPODB:clinically_tested_withdrawn_phase_2
- REPODB:clinically_tested_withdrawn_phase_2_or_phase_3
- REPODB:clinically_tested_withdrawn_phase_3
- SNOMED:plays_role
broad_mappings:
- DRUGBANK:treats
- SEMMEDDB:TREATS
- WIKIDATA_PROPERTY:P2175
- MONDO:disease_responds_to
mixin: true
domain: chemical or drug or treatment
alias: treats
range: disease or phenotypic feature